EFS
GSK icon

Essex Financial Services’s GSK GSK Stock Holding History

Essex Financial Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$392K Buy
7,103
+1,073
+18% +$58.1K 0.02% 531
2025
Q4 		$296K Buy
6,030
+909
+18% +$42.4K 0.02% 605
2025
Q3 		$221K Sell
5,121
-942
-16% -$36.8K 0.01% 683
2025
Q2 		$233K Buy
+6,063
New +$232K 0.02% 618
2025
Q1 		– Sell
-6,599
Closed -$223K – 647
2024
Q4 		$223K Buy
6,599
+1,008
+18% +$36.3K 0.02% 573
2024
Q3 		$212K Sell
5,591
-1,534
-22% -$62.8K 0.02% 585
2024
Q2 		$285K Buy
7,125
+2,007
+39% +$84.4K 0.02% 497
2024
Q1 		$219K Buy
+5,118
New +$211K 0.02% 488
2022
Q3 		– Sell
-4,740
Closed -$258K – 472
2022
Q2 		$258K Buy
4,740
+320
+7% +$17.7K 0.03% 396
2022
Q1 		$241K Buy
4,420
+1
+0% +$54 0.02% 424
2021
Q4 		$244K Buy
4,419
+109
+3% +$5.67K 0.02% 416
2021
Q3 		$206K Sell
4,310
-296
-6% -$14.9K 0.02% 437
2021
Q2 		$229K Buy
+4,606
New +$221K 0.03% 398
2021
Q1 		– Sell
-4,421
Closed -$203K – 357
2020
Q4 		$203K Buy
+4,421
New +$203K 0.04% 305
2020
Q1 		– Sell
-5,578
Closed -$328K – 258
2019
Q4 		$328K Buy
5,578
+14
+0.3% +$779 0.09% 196
2019
Q3 		$297K Sell
5,564
-28
-0.5% -$1.44K 0.1% 188
2019
Q2 		$280K Buy
5,592
+215
+4% +$10.8K 0.08% 190
2019
Q1 		$281K Buy
5,377
+12
+0.2% +$600 0.08% 178
2018
Q4 		$256K Sell
5,365
-1,083
-17% -$53.3K 0.08% 198
2018
Q3 		$324K Buy
6,448
+100
+2% +$5.08K 0.07% 210
2018
Q2 		$320K Buy
6,348
+173
+3% +$8.71K 0.08% 204
2018
Q1 		$302K Buy
6,175
+492
+9% +$22.9K 0.06% 264
2017
Q4 		$252K Sell
5,683
-840
-13% -$38.8K 0.06% 235
2017
Q3 		$331K Buy
6,523
+60
+0.9% +$3.04K 0.08% 198
2017
Q2 		$348K Buy
6,463
+437
+7% +$23.3K 0.07% 242
2017
Q1 		$318K Sell
6,026
-910
-13% -$46.2K 0.07% 244
2016
Q4 		$334K Sell
6,936
-615
-8% -$30.4K 0.07% 235
2016
Q3 		$402K Buy
7,551
+177
+2% +$9.71K 0.1% 199
2016
Q2 		$399K Sell
7,374
-632
-8% -$33.3K 0.1% 196
2016
Q1 		$406K Sell
8,006
-649
-7% -$32.3K 0.1% 195
2015
Q4 		$437K Sell
8,655
-1,256
-13% -$64K 0.1% 192
2015
Q3 		$476K Sell
9,911
-816
-8% -$42.5K 0.12% 178
2015
Q2 		$558K Sell
10,727
-168
-2% -$9.46K 0.14% 161
2015
Q1 		$629K Sell
10,895
-2,233
-17% -$128K 0.16% 149
2014
Q4 		$701K Buy
13,128
+4,854
+59% +$272K 0.18% 136
2014
Q3 		$475K Hold
8,274
– – 0.14% 166
2014
Q2 		$553K Sell
8,274
-284
-3% -$19.2K 0.17% 146
2014
Q1 		$572K Buy
8,558
+2,524
+42% +$171K 0.19% 126
2013
Q4 		$403K Buy
6,034
+2,516
+72% +$163K 0.14% 156
2013
Q3 		$221 Sell
3,518
-1,620
-32% -$104K 0.07% 234
2013
Q2 		$321K Buy
+5,138
New +$326K 0.11% 179

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Essex Financial Services's GSK Position: Q1 2026 in Review

Essex Financial Services increased its GSK (GSK) stake by 18% in Q1 2026, buying an estimated $58.1K and bringing the position to 7,103 shares worth $392K. The position accounts for 0.02% of the portfolio, ranked #531.

Essex Financial Services first reported a position in GSK in Q2 2013 and has held it in 41 quarters since. The position peaked at $701K in Q4 2014. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Essex Financial Services held 7,103 shares of GSK worth $392K as of Q1 2026.
  • Essex Financial Services bought 1,073 GSK shares in Q1 2026, an estimated $58.1K.
  • GSK made up 0.02% of Essex Financial Services's portfolio in Q1 2026, its #531 holding.
  • Essex Financial Services first reported a position in GSK in Q2 2013 and has held it in 41 quarters since.
  • Essex Financial Services's GSK position peaked at $701K in Q4 2014.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.